Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Alzheimer's Disease

Free Subscription 06.10.2025 17 Alzheimers Dement 1 Am J Alzheimers Dis Other Demen 1 BMC Geriatr 1 BMC Neurol 1 BMJ 1 Brain 3 Brain Res 1 Drugs 10 J Alzheimers Dis 1 J Am Geriatr Soc 1 J Biol Chem 4 J Neurol 1 J Neurosci 3 JAMA 4 Lancet 1 Nat Rev Neurol 2 Neurobiol Dis 1 Neurology 1 Neuropsychology 1 Neuroreport 1 Neurosci Lett 2 PLoS One 1 Rev Neurol (Paris) 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. VAQUE-ALCAZAR L, Videla L, Benejam B, Del Hoyo Soriano L, et al
   Generational effects in Down syndrome: Enriched environment enhances functionality without reducing Alzheimer's disease risk.
   Alzheimers Dement. 2025;21:e70447.
   PubMed         Abstract available
   
   
2. YANG L, Chan M, Sheng J, Qi S, et al
   Decoding adipose-brain crosstalk: Distinct lipid cargo in human adipose-derived extracellular vesicles modulates amyloid aggregation in Alzheimer's disease.
   Alzheimers Dement. 2025;21:e70603.
   PubMed         Abstract available
   
   
3. YANG AJT, Mohammad A, Crozier RWE, Maddalena L, et al
   Differences in inflammatory markers, mitochondrial function, and synaptic proteins in male and female Alzheimer's disease post mortem brains.
   Alzheimers Dement. 2025;21:e70645.
   PubMed         Abstract available
   
   
4. MARKOVA TZ, Fonseca CS, Ciampa CJ, Murphy A, et al
   Defining the contributions of tau pathology in the amygdala to increasing depressive symptoms in aging.
   Alzheimers Dement. 2025;21:e70740.
   PubMed         Abstract available
   
   
5. SOLEIMANI-MEIGOONI DN, Pezzoli S, Blazhenets G, La Joie R, et al
   Calibration of multisite raters for prospective visual reads of amyloid PET scans.
   Alzheimers Dement. 2025;21:e70732.
   PubMed         Abstract available
   
   
6. ABUGHOFAH Y, Risacher SL, Unverzagt FW, Farlow MR, et al
   The Cognitive Change Index in the Alzheimer's Disease Research Center setting: Self- and informant-ratings for perceived cognitive decline.
   Alzheimers Dement. 2025;21:e70754.
   PubMed         Abstract available
   
   
7. ERATNE D, Kang M, Malpas CB, Dang C, et al
   Plasma p-tau217, NfL, GFAP diagnostic performance and biomarker profiles in Alzheimer's disease, frontotemporal dementia, and psychiatric disorders, in a prospective unselected neuropsychiatry memory clinic.
   Alzheimers Dement. 2025;21:e70717.
   PubMed         Abstract available
   
   
8. BARBER D, Hasselmo ME, Rice HC
   Modeling presynaptic inhibition by the amyloid precursor protein demonstrates one potential mechanism for preventing runaway synaptic modification in Alzheimer's disease.
   Alzheimers Dement. 2025;21:e70748.
   PubMed         Abstract available
   
   
9. VERBERK IMW, Gouda M, Antwi-Berko D, van Leeuwenstijn M, et al
   Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium.
   Alzheimers Dement. 2025;21:e70752.
   PubMed         Abstract available
   
   
10. OUELLETTE A, O'Connell K, Kaczorowski C
    Evaluation of hippocampal DLGAP2 overexpression on cognition, synaptic function, and dendritic spine structure in a translationally relevant AD mouse model.
    Alzheimers Dement. 2025;21:e70728.
    PubMed         Abstract available
    
    
11. DAVID MCB, Kolanko MA, Parker TD, Nilforooshan R, et al
    Catecholaminergic nucleus integrity and Alzheimer's pathology, symptoms, and progression.
    Alzheimers Dement. 2025;21:e70749.
    PubMed         Abstract available
    
    
12. LIU H, Weakley AM, Dodge HH, Liu X, et al
    Longitudinal methods for Alzheimer's cognitive status prediction with deep learning.
    Alzheimers Dement. 2025;21:e70488.
    PubMed         Abstract available
    
    
13. MCGRATH S, Hull E, Dunbar MD, Prescott J, et al
    The companion dog as a translational model for Alzheimer's disease: Development of a longitudinal research platform and post mortem protocols.
    Alzheimers Dement. 2025;21:e70630.
    PubMed         Abstract available
    
    
14. EDWARDS NC, Lao PJ, Alshikho MJ, Ericsson OM, et al
    Alzheimer's disease diagnostic progression is associated with cerebrovascular disease and neuroinflammation in adults with Down syndrome.
    Alzheimers Dement. 2025;21:e70726.
    PubMed         Abstract available
    
    
15. ALMANZA DLV, Trevisiol A, Koletar MM, Lai AY, et al
    High-caloric intake rescues early symptomatic AD-induced hippocampal neurovascular coupling deficits.
    Alzheimers Dement. 2025;21:e70708.
    PubMed         Abstract available
    
    
16. POVALA G, Bellaver B, Bastiani MA, Ferrari-Souza JP, et al
    Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegeneration.
    Alzheimers Dement. 2025;21:e70746.
    PubMed         Abstract available
    
    
17. VILLENEUVE S, Poirier J, Breitner JCS, Tremblay-Mercier J, et al
    The PREVENT-AD cohort: Accelerating Alzheimer's disease research and treatment in Canada and beyond.
    Alzheimers Dement. 2025;21:e70653.
    PubMed         Abstract available
    
    

    
    Am J Alzheimers Dis Other Demen

18. ZHOU F, Zhao Z, Dai J, Xu J, et al
    Olfactory Testing With Focus on Odor Identification for Early Detection of Alzheimer's Disease in Mild Cognitive Impairment.
    Am J Alzheimers Dis Other Demen. 2025;40:15333175251385615.
    PubMed         Abstract available
    
    

    
    BMC Geriatr

19. ZOU M, Xu SS, Zhu SG, Yuan CX, et al
    Elevated D-dimer levels after lecanemab infusions: a case report.
    BMC Geriatr. 2025;25:742.
    PubMed         Abstract available
    
    

    
    BMC Neurol

20. DONG X, Li Y, Hao J, Zhou P, et al
    Convolutional neural network models of structural MRI for discriminating categories of cognitive impairment: a systematic review and meta-analysis.
    BMC Neurol. 2025;25:400.
    PubMed         Abstract available
    
    

    
    BMJ

21. NOGRADY B
    Lecanamab: Controversial Alzheimer's drug approved by Australian drugs regulator after two rejections.
    BMJ. 2025;390:r2056.
    PubMed        
    
    

    
    Brain

22. VERBERK IMW, van Harten AC, van der Flier WM
    Opposing views or like-minded? International Working Group and Alzheimer's Association criteria.
    Brain. 2025 Oct 1:awaf366. doi: 10.1093.
    PubMed        
    
    

    
    Brain Res

23. WANG Y, Zhao D, Kong T, Ni Y, et al
    Associations between reproductive milestones and Alzheimer's disease risk: a Mendelian randomization study.
    Brain Res. 2025;1867:149972.
    PubMed         Abstract available
    
    
24. KAKOTY V, Goh KW, Kesharwani P, Ko YT, et al
    BNIP3L/NIX-mediated mitophagy: Future directions in Alzheimer's disease.
    Brain Res. 2025;1867:149970.
    PubMed         Abstract available
    
    
25. MAK KK, Nam KJ, Chuang YF, Chen LK, et al
    Matrix metalloproteinases and tissue inhibitors of metalloproteinases as the biomarkers of Alzheimer's disease: a meta-analysis.
    Brain Res. 2025 Sep 23:149954. doi: 10.1016/j.brainres.2025.149954.
    PubMed         Abstract available
    
    

    
    Drugs

26. ABUSHAKRA S, Power A, Watson D, Porsteinsson A, et al
    Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEepsilon4/epsilon4 Homozygotes with Early Alzheimer's Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial.
    Drugs. 2025 Sep 28. doi: 10.1007/s40265-025-02250.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

27. DUCHESNE S, Potvin O, Hudon C, Bocti C, et al
    A brain health framework with application to the study of neurodegeneration.
    J Alzheimers Dis. 2025;107:960-972.
    PubMed         Abstract available
    
    
28. AGBOJI A
    Navigating life after diagnosis: Insights from people with early-stage dementia.
    J Alzheimers Dis. 2025;107:997-998.
    PubMed         Abstract available
    
    
29. CHEN C, Babulal GM
    Longitudinal associations between plasma biomarkers and changes in naturalistic driving behaviors in older adults.
    J Alzheimers Dis. 2025;107:1275-1284.
    PubMed         Abstract available
    
    
30. RICO V, Zelinsky M, Ford PJ, Leverenz J, et al
    Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus.
    J Alzheimers Dis. 2025 Sep 25:13872877251379076. doi: 10.1177/13872877251379076.
    PubMed         Abstract available
    
    
31. ROJAS-ALVAREZ A, Chung H, Cabrero Castro JE, Umucu E, et al
    Profile and disparities in health outcomes for older adults with dual diagnoses of diabetes and Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 25:13872877251380260. doi: 10.1177/13872877251380260.
    PubMed         Abstract available
    
    
32. MUKESHA D, Sarter M, Dubray M, Durand F, et al
    Targeted serum metabolomic profiling and machine learning approach in Alzheimer's disease using the Alzheimer's disease diagnostics clinical study (ADDIA) cohort.
    J Alzheimers Dis. 2025 Sep 26:13872877251378653. doi: 10.1177/13872877251378653.
    PubMed         Abstract available
    
    
33. HOU H, Yu J, Hao S, Zhang X, et al
    Electroencephalography microstates as biomarkers for screening Alzheimer's disease: Feasibility analysis and a machine learning classification scheme.
    J Alzheimers Dis. 2025 Sep 26:13872877251379072. doi: 10.1177/13872877251379072.
    PubMed         Abstract available
    
    
34. TANAKA E, Nihashi T, Kato T, Arahata Y, et al
    Modulation of middle-latency somatosensory evoked magnetic field waveforms associated with the pathophysiological states of Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 26:13872877251379466. doi: 10.1177/13872877251379466.
    PubMed         Abstract available
    
    
35. BOONGIRD C, Anothaisintawee T, Tearneukit W, Wongpipathpong W, et al
    Bridging the gap: Efficacy of combined therapies for cognitive, behavioral, and functional outcomes in Alzheimer's disease - results from a systematic review and network meta-analysis.
    J Alzheimers Dis. 2025 Oct 3:13872877251378354. doi: 10.1177/13872877251378354.
    PubMed         Abstract available
    
    
36. LYU J, Zhang W, De J, Shan B, et al
    The impact of music-based intervention on cognitive function and brain functional magnetic resonance imaging in people with mild Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 3:13872877251379419. doi: 10.1177/13872877251379419.
    PubMed         Abstract available
    
    

    
    J Am Geriatr Soc

37. GASTER B, Zigman Suchsland M, Liao JM, McKiddy S, et al
    A Large Health System Quality Improvement Intervention Providing Training and Tools to Improve Detection of Cognitive Impairment in Primary Care.
    J Am Geriatr Soc. 2025;73:2886-2892.
    PubMed         Abstract available
    
    

    
    J Biol Chem

38. SHIVKUMAR A, Berg KR, Sibucao KC, Leriche G, et al
    Nootropic benzothiazoles promote dendritic spine formation by targeting fascin-1.
    J Biol Chem. 2025;301:110572.
    PubMed         Abstract available
    
    

    
    J Neurol

39. SCHMIDT CC, Bardakan MM, Jaeger E, Richter N, et al
    Apraxic deficits predict general cognitive impairment in patients with biomarker-verified Alzheimer's pathology.
    J Neurol. 2025;272:654.
    PubMed         Abstract available
    
    
40. MAZZEO S, Boveri S, Bortolin E, Bruschi G, et al
    Data-driven subtypes of subjective cognitive decline: neuropsychological profiles, Alzheimer's disease biomarkers, and clinical trajectories.
    J Neurol. 2025;272:669.
    PubMed         Abstract available
    
    
41. WADOP YN, Bernal R, Njamnshi WY, Satizabal CL, et al
    Altered gut microbiota mediates the association between APOE genotype and amyloid-beta accumulation in middle-aged adults.
    J Neurol. 2025;272:670.
    PubMed         Abstract available
    
    
42. ELKANA O, Beheshti I
    Brain age as an accurate biomarker of preclinical cognitive decline: evidence from a 12-year longitudinal study.
    J Neurol. 2025;272:672.
    PubMed         Abstract available
    
    

    
    J Neurosci

43. 
    Erratum: Barron et al., "Ligand for Translocator Protein Reverses Pathology in a Mouse Model of Alzheimer's Disease".
    J Neurosci. 2025;45:e1634252025.
    PubMed        
    
    

    
    JAMA

44. ANDERER S
    Alzheimer Disease Exacerbated by Air Pollution, Study Suggests.
    JAMA. 2025 Sep 26. doi: 10.1001/jama.2025.13889.
    PubMed        
    
    
45. RUBIN R
    Trying to Unravel Why Alzheimer Disease Is More Common in Women.
    JAMA. 2025 Sep 26. doi: 10.1001/jama.2025.16269.
    PubMed        
    
    
46. ANDERER S
    First Antiamyloid Injectable Approved for Early Alzheimer Disease.
    JAMA. 2025 Sep 26. doi: 10.1001/jama.2025.13885.
    PubMed        
    
    

    
    Lancet

47. THE LANCET
    Alzheimer's disease: are health systems ready?
    Lancet. 2025;406:1313.
    PubMed        
    
    
48. FRISONI GB, Hansson O, Nichols E, Garibotto V, et al
    New landscape of the diagnosis of Alzheimer's disease.
    Lancet. 2025;406:1389-1407.
    PubMed         Abstract available
    
    
49. FOX NC, Belder C, Ballard C, Kales HC, et al
    Treatment for Alzheimer's disease.
    Lancet. 2025;406:1408-1423.
    PubMed         Abstract available
    
    
50. FRISONI GB, Aho E, Brayne C, Ciccarelli O, et al
    Alzheimer's disease outlook: controversies and future directions.
    Lancet. 2025;406:1424-1442.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

51. WOOD H
    Timing of hormone replacement therapy could influence Alzheimer disease risk.
    Nat Rev Neurol. 2025 Oct 1. doi: 10.1038/s41582-025-01149.
    PubMed        
    
    

    
    Neurobiol Dis

52. YU Y, Zhou RZ, Nilsson P, Winblad B, et al
    Altered APP trafficking drives amyloidogenic processing in primary neurons from the App(NL-F) knock-in mouse model of Alzheimer's disease.
    Neurobiol Dis. 2025 Sep 28:107129. doi: 10.1016/j.nbd.2025.107129.
    PubMed         Abstract available
    
    
53. OLAYINKA OA, O'Neill N, Empawi JA, Bock P, et al
    Single nucleus RNA sequencing unveils relationship between microglia and endothelial cells in mixed Alzheimer's disease and vascular pathology.
    Neurobiol Dis. 2025 Sep 27:107128. doi: 10.1016/j.nbd.2025.107128.
    PubMed         Abstract available
    
    

    
    Neurology

54. MOURTZI N, Charisis S, Ntanasi E, Hatzimanolis A, et al
    Longitudinal Association of a Polygenic Risk Score for Plasma T-Tau With Incident Alzheimer Dementia and Mild Cognitive Impairment.
    Neurology. 2025;105:e213904.
    PubMed         Abstract available
    
    

    
    Neuropsychology

55. ROYALL DR, Palmer RF
    Affliction class moderates the dementing impact of amyloidopathy.
    Neuropsychology. 2025;39:587-598.
    PubMed         Abstract available
    
    

    
    Neuroreport

56. ZHANG C, Song C, Li X, Duan Y, et al
    Classification of mild cognitive impairment developmental trajectories using multispatial scale structural brain networks.
    Neuroreport. 2025;36:976-987.
    PubMed         Abstract available
    
    

    
    Neurosci Lett

57. COLIN-MARTINEZ E, Arias C
    Intracerebral administration of Wnt7a improves memory performance and increases synaptophysin expression in the 3xTg-AD mouse model.
    Neurosci Lett. 2025;865:138336.
    PubMed         Abstract available
    
    

    
    PLoS One

58. ZUBAIR M, Jaffar A, Hussain S, Akram S, et al
    Alzheimer's disease classification using a hybrid deep learning approach with multi-layer U-net segmentation and XAI driven analysis.
    PLoS One. 2025;20:e0332572.
    PubMed         Abstract available
    
    
59. KOKORELIAS KM, Stall NM, Wasilewski M, Gignac MAM, et al
    Navigating the dementia caregiving journey: A scoping review protocol of interventions and their responsiveness to caregivers' evolving needs across the illness trajectory.
    PLoS One. 2025;20:e0333475.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

60. DUMURGIER J, Defontaines B, Gallouj K, Garcin B, et al
    Diagnosis of Alzheimer's disease: Recommendations from the French Federation of Memory Clinics.
    Rev Neurol (Paris). 2025 Sep 30:S0035-3787(25)00611.
    PubMed         Abstract available
    
    

    
    Science

61. CHANG M, Krussel S, Parajuli LK, Kim J, et al
    Intercellular communication in the brain through a dendritic nanotubular network.
    Science. 2025;390:eadr7403.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.